Fusion Pharmaceuticals Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.4 USD/shares, a 11.1% increase year-over-year.
  • Fusion Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -1.4 USD/shares, a 29.6% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -1.45 USD/shares, a 27.5% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was -2 USD/shares, a 5.26% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1 $0 +$0.05 +11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1 $0 +$0.18 +32.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$2 $0 +$0.30 +54.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$2 $0 +$0.06 +13.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$2 $0 +$0.01 +2.17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$2 -$1 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$1 $0 -22.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $0 +$0.19 +30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.